A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC)

✍ Scribed by Mavroudis, D; Papadakis, E; Veslemes, M; Agelidou, M; Tsiafaki, X; Agelidou, G; Pavlakos, G; Anagnostopoulou, O; Giannakakis, Th; Ziras, N; Bania, M; Lambrakis, Ch; Kouroussis, Ch; Samonis, G; Bachlitzanakis, N; Georgoulias, V

• Book ID: 118569636
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 103 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80091-4